Alkem subsidiary offers to acquire stake in Occlutech
pre-market1 source ↓written by the desknot a recommendation
- of Occlutech Holding
- 51-55%
- to finalize
- 30 June 2026
Alkem Laboratories’ subsidiary, Alkem Medtech, has made a binding offer to acquire 51-55% of Occlutech Holding AG for cash. The acquisition, planned to finalize by 30 June 2026, is subject to customary closing conditions. This move expands Alkem's footprint in the medtech sector, potentially enhancing its growth prospects in Europe.
Not investment advice. For informational purposes only.